Answer
Gefapixant citrate is excreted in animal milk, and risk to breastfed newborns or infants cannot be excluded; whether to stop breastfeeding or stop or avoid Lyfnua therapy must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Lyfnua 45 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked